iShares Health Innovation Active ETF (NYSEARCA:BMED) Short Interest Down 40.0% in January

Posted by Anthony Miller on Feb 14th, 2026

iShares Health Innovation Active ETF (NYSEARCA:BMED – Get Free Report) saw a large decrease in short interest in January. As of January 30th, there was short interest totaling 3,799 shares, a decrease of 40.0% from the January 15th total of 6,335 shares. Approximately 1.2% of the company’s stock are short sold. Based on an average daily volume of 11,722 shares, the days-to-cover ratio is currently 0.3 days. Based on an average daily volume of 11,722 shares, the days-to-cover ratio is currently 0.3 days. Approximately 1.2% of the company’s stock are short sold.

iShares Health Innovation Active ETF Trading Up 0.4%

iShares Health Innovation Active ETF stock traded up $0.13 during midday trading on Friday, reaching $30.48. The stock had a trading volume of 1,533 shares, compared to its average volume of 7,568. The company has a fifty day moving average price of $30.84 and a two-hundred day moving average price of $28.59. iShares Health Innovation Active ETF has a 12 month low of $20.57 and a 12 month high of $32.19. The company has a market capitalization of $9.75 million, a P/E ratio of 24.91 and a beta of 0.84.

About iShares Health Innovation Active ETF

(Get Free Report)

The BlackRock Future Health ETF (BMED) is an exchange-traded fund that is based on the MSCI All Country World index. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is managed by BlackRock.